Seayoung Yim's Jar of Fat Wins 15th Annual Yale Drama Series Prize | Playbill

Awards Seayoung Yim's Jar of Fat Wins 15th Annual Yale Drama Series Prize

Jar of Fat is an absurdist comedy about the close bond between two Korean American sisters.

Seayoung Yim Laura Dux Photography

The 2022 Yale Drama Series Prize has been awarded to Seayoung Yim for her play Jar of Fat. Yim's win follows the prize's first ever shortlist, released in February. Yim receives the David Charles Horn Prize of $10,000, as well as publication by Yale University Press, in addition to a staged reading.

“When I first received the news at winning this prize, I was very much in shock and disbelief,” said Yim. “After recovering from the initial shock, I feel honored and grateful to receive this award. I thank the cast and director, Tatyana-Marie Carlo, of this play’s first workshop production, [and] my graduate school mentors, Lisa D’Amour and Julia Jarcho, for supporting the development of this play. I am also grateful to my artistic communities in Providence and Seattle for nurturing my work. And thanks to my partner, Mario Gómez, whose support has fortified and inspired me.

"Jar of Fat is a darkly comedic Korean American fairy tale about the allure and danger entangled within the quest for beauty and thinness,” Yim continued. “I offer this play as a struck match to burn some of the accumulated rage at what fatphobia steals from us every day: grace, space, possibility, and breath. As a Korean American, it was important to have this conversation about fatphobia and attractiveness in a culturally specific context to explore the ways these issues present themselves differently from the mainstream Western norms. It is my long-term hope that we collectively dream about and build the capacity to honor all bodies in their ever-changing forms.”

To learn more about Yim's work, please visit

Today’s Most Popular News:

Blocking belongs
on the stage,
not on websites.

Our website is made possible by
displaying online advertisements to our visitors.

Please consider supporting us by
whitelisting with your ad blocker.
Thank you!